| Aurelie Doricent, | |
|
11830 Nw 25th Street, Plantation, FL 33323-1200 | |
| (754) 252-6690 | |
| (800) 574-5053 |
| Full Name | Aurelie Doricent |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 11830 Nw 25th Street, Plantation, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033764048 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APRN11003901 (Florida) | Primary |
| Entity Name | Jardin Deden, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740804178 PECOS PAC ID: 1658793732 Enrollment ID: O20200618000429 |
News Archive
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
A Japanese research team has successfully developed a system to predict the severity of Alport syndrome, a serious hereditary kidney disease that occurs in about 1 out of 5,000 people in the US. Patients with Alport syndrome have abnormalities in the causative protein, type IV collagen, that often lead to chronic renal dysfunction requiring dialysis.
A low level of response (LR) to alcohol is one of several genetically influenced characteristics that may increase an individual's risk for heavy drinking and alcohol problems. A new study has confirmed key elements of a LR-based model of risk through examination of a large sample of adolescent boys and girls in the United Kingdom, moving beyond smaller U.S.-based samples and to younger subjects.
Mitnick Law Office has filed a motion for declaratory judgment in the Superior Court of New Jersey, asking the Court to declare that hemp-derived CBD products are legal to possess and to be sold in the State of New Jersey and should not be considered marijuana.
Acceleron Pharma, a biopharmaceutical company developing protein therapeutics for cancer and orphan disease, today announced that the Gynecologic Oncology Group (GOG) initiated a phase 2 study of dalantercept in patients with persistent or recurrent ovarian, fallopian tube, or primary peritoneal cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aurelie Doricent, 11830 Nw 25th Street, Plantation, FL 33323-1200 Ph: (754) 252-6690 | Aurelie Doricent, 11830 Nw 25th Street, Plantation, FL 33323-1200 Ph: (754) 252-6690 |
News Archive
The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).
A Japanese research team has successfully developed a system to predict the severity of Alport syndrome, a serious hereditary kidney disease that occurs in about 1 out of 5,000 people in the US. Patients with Alport syndrome have abnormalities in the causative protein, type IV collagen, that often lead to chronic renal dysfunction requiring dialysis.
A low level of response (LR) to alcohol is one of several genetically influenced characteristics that may increase an individual's risk for heavy drinking and alcohol problems. A new study has confirmed key elements of a LR-based model of risk through examination of a large sample of adolescent boys and girls in the United Kingdom, moving beyond smaller U.S.-based samples and to younger subjects.
Mitnick Law Office has filed a motion for declaratory judgment in the Superior Court of New Jersey, asking the Court to declare that hemp-derived CBD products are legal to possess and to be sold in the State of New Jersey and should not be considered marijuana.
Acceleron Pharma, a biopharmaceutical company developing protein therapeutics for cancer and orphan disease, today announced that the Gynecologic Oncology Group (GOG) initiated a phase 2 study of dalantercept in patients with persistent or recurrent ovarian, fallopian tube, or primary peritoneal cancer.
› Verified 5 days ago
Mrs. Carmelle Alexis Casimir, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1776 N Pine Island Rd Ste 106, Plantation, FL 33322 Phone: 954-376-3739 Fax: 855-618-6655 | |
Ralitza Georgieva, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 7420 Nw 5th St, Suite 103, Plantation, FL 33317 Phone: 954-474-4704 Fax: 954-587-8686 | |
Jonelle A Mattis, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8201 Peters Rd Ste 1000, Plantation, FL 33324 Phone: 877-964-9378 | |
Ms. Lenette Blanco, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8251 W Broward Blvd Ste 103, Plantation, FL 33324 Phone: 954-255-7310 Fax: 954-255-1530 | |
Angelica Berrio, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10241 W Broward Blvd, Plantation, FL 33324 Phone: 786-985-8901 | |
Dr. Juliette Drexler, DNP, APRN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 700 Sw 78th Ave Apt 416, Plantation, FL 33324 Phone: 954-401-2852 | |
Mrs. Yasnay Arias, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8251 W Broward Blvd, Suite 103, Plantation, FL 33324 Phone: 954-255-7310 Fax: 954-255-1530 |